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INTRODUCTION:  Rapidly  enlarging  mammary  tumors,  including  invasive  breast tumors,  are  clinically  rare.
Invasive micropapillary  carcinoma  (IMPC)  of the  breast  is known  to have  aggressive  behavior  and  poor
clinical  course  compared  to invasive  ductal  carcinoma.
CASE  PRESENTATION:  An  87-year-old  woman  presented  with  a  rapidly  enlarging  tumor  of the  right  breast
over the  course  of  3  weeks.  Ultrasonography  and computed  tomography  of  the  chest  revealed  a  giant
tumor  located  on the  right  chest  wall,  with  heterogeneous  parenchymal  components  and  several  cystic
lesions.  Emergency  mastectomy  was  performed  because  of  rapid  tumor  enlargement  complicated  by
hemorrhage.  Histopathological  diagnosis  conﬁrmed  a papillotubular  invasive  ductal  carcinoma  with  an
IMPC component.  Tumor  cells  were  negative  for  estrogen  and  progesterone  receptors,  and  the  human
epidermal  growth  factor  receptor  2  score  was  2+.
DISCUSSION:  There  has been  only  one  report  of breast  carcinoma  with  rapid  enlargement  caused  by
spontaneous  intratumoral  hemorrhage  to  date.  IMPC  is associated  with  a high  incidence  of axillary  lymph
node  metastases,  frequent  local  recurrence,  and a poor  clinical  outcome.  In the  present  case,  the speciﬁc
breast  cancer  type  can  be considered  as potential  factors  responsible  for  hemorrhage  induction  within
the  tumor  that further  enhanced  rapid  tumor  growth.
CONCLUSION:  IMPC  is a rare,  clinically  aggressive  variant  of  invasive  ductal  carcinoma.  Owing  to its
aggressive  clinical  behaviors,  surgeons  should  readily  recognize  the  morphology  of IMPC.
© 2017  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Rapidly enlarging mammary tumors are rare, and there has
een only one report of breast carcinoma associated with rapid
nlargement due to intratumoral hemorrhage to date [1]. Invasive
icropapillary carcinoma (IMPC) and carcinoma with micropap-
llary carcinoma component, initially described by Fisher et al.
n 1980 [2], is known to have a higher rate of lympho-vascular
nvasion, high nuclear grade, and a propensity for locoregional
ecurrence compared to invasive ductal carcinoma [3]. We  herein
resent a case of papillotubular invasive ductal carcinoma with
Abbreviations: IMPC, invasive micropapillary carcinoma; ER, Estrogen receptor;
gR, progesterone receptor; HER2, human epidermal growth factor receptor 2; IDC,
nvasive ductal carcinoma.
∗ Corresponding author at: Department of Surgery, Moriya Daiichi General Hos-
ital, 1-17 Matsumaedai, Moriya, Ibaraki, 302-0102, Japan.
E-mail address: motowide@aol.com (M.  Watanabe).
ttp://dx.doi.org/10.1016/j.ijscr.2017.07.048
210-2612/© 2017 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
an IMPC component that showed a rapid increase in size due to
intra-tumoral hemorrhage.
This work has been written in accordance with the SCARE crite-
ria [4].
2. Case presentation
An 87-year-old woman  presented with a rapidly enlarging
tumor of the right breast over the course of a few weeks. Her past
medical history was  signiﬁcant for hyperlipidemia, but she had no
history of malignancy or thoracic injury. Before three weeks ago
she did not realize the breast tumor at all, and she had used no
drugs with anticoagulants or anti-platelets. Physical examination
showed a tumor in the outer area of the right breast, measuring
approximately 10 × 10 cm (Fig. 1). Laboratory data revealed mild
anemia (hemoglobin level 10.3 g/dL), and elevated levels of carci-
noembryonic antigen (8.0 ng/mL) and carbohydrate antigen 15-3
(40.9 U/mL). Ultrasonography showed a 15 × 12 cm tumor consist-
ing of solid and cystic components with polygonal and well deﬁned
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. A tumor measuring 10 × 10 cm located in the lateral upper quadrant of the
right breast.
Fig. 2. Ultrasonography of the right breast showing a tumor intermingled with
heterogeneous parenchymal parts and several cystic lesions.
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Fig. 4. The histopathological specimen showing mucus production and hemorrhageig. 3. Computed tomography of the chest showing a giant tumor consisting of
eterogeneous parenchymal parts and several cystic lesions.
ut rough borders (Fig. 2). Parenchymal components showed mixed
cogenicity. Cystic lesion showed a ﬂuid–ﬂuid level, suspicious
f intracystic hemorrhage. Enlarged axillary lymph node was  not
dentiﬁed. Mammography was not performed because of the size of
umor and suspicion of intratumor hemorrhage. Computed tomog-
aphy of the chest revealed a giant tumor located on the right chest
all, with heterogeneous parenchymal components and several
ystic lesions (Fig. 3). Fine-needle aspiration of the cystic lesion
as performed, and 300 mL  of old blood was drained. Core nee-
le biopsy of the tumor was performed, but the specimen showed
o malignant ﬁndings. Four days later, urgent mastectomy was
erformed because of rapid tumor enlargement complicated by
emorrhage. Fascia of pectoralis major was removed with the
umor, and lymph node dissection was not performed because ofin  the cyst lumen and around the alveolar structures. The inset image shows the
micropapillary components consisting of small, free clusters of tumor cells in the
lumen.
no lymph node swelling. The skin was  directly sutured because it
had sufﬁcient extensibility.
Macroscopically, the tumor was  14 × 12 × 6 cm in size, and con-
sisted of a combination of solid lesions and multi-lobulated cysts.
Microscopical examination revealed mucus production and hem-
orrhage in the cyst lumen and around the alveolar structures. The
tumor cells were growing in cribriform, tubular, papillary, and
solid alveolar patterns. In some parts of the lumen, micropapil-
lary components consisting of small, free clusters of tumor cells
were observed (Fig. 4). Histopathological diagnosis conﬁrmed an
invasive ductal carcinoma composed of a papillotubular carcinoma
with an IMPC component. The margin of the resected specimen was
free from cancer cells, and no ﬁltration was  observed with the fas-
cia. Tumor cells were negative for the estrogen receptor (ER) and
progesterone receptor (PgR), and the human epidermal growth fac-
tor receptor 2 (HER2) score was  2+. Ki-67 proliferation index was
22%. The patient’s postoperative course was  uneventful and she was
discharged on the eighth postoperative day. She refused all adju-
vant treatments with hormone therapy and radiation therapy. Ten
months later, right axillary lymph node swelling was found, and
she was underwent lymph node dissection. She has remained free
from relapse for one year after the second operation.
3. DiscussionA rapidly enlarging breast tumor is clinically rare, and more
likely to be a phyllodes tumor rather than a breast carcinoma. There
has been only one reports of breast carcinoma with rapid enlarge-
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ent caused by spontaneous intratumoral hemorrhage to date1,
xcept for bleeding due to trauma.
IMPC is a distinct histological sub-type of breast carcinoma
hat was initially described by Fisher et al. [2] in 1980. Morpho-
ogically, this tumor is characterized by delicate pseudopapillary
tructures that lack ﬁbrovascular cores and ﬂoat freely in empty,
lear spaces formed by a stromal, ﬁbrocollagenous, sponge-like
etwork—a pattern that mimics extensive lymphatic permeation
5]. IMPC is associated with a high incidence of axillary lymph node
etastases, frequent local recurrence, and a poor clinical outcome
6]. Shi et al. reported that overall survival and recurrence free sur-
ival were poorer in the IMPC group than in the invasive ductal
arcinoma(IDC) group [7], and Chen et al. found that IMPC patients
ave poorer recurrence-free survival and loco-regional recurrence-
ree survival than IDC patients [8].
Pathologically, a pure IMPC is rare, and the amount of micropap-
llary architecture in a tumor required for the diagnosis of IMPC has
ot yet been well established [9]. The 2003 World Health Organi-
ation classiﬁcation of breast tumors listed IMPC as a subtype of
nvasive carcinoma; however, no speciﬁc percentage of the IMPC
omponent within the breast tumor has been proposed as a crite-
ion for the IMPC diagnosis [6,10].
Breast cancer has been characterized by 5 intrinsic molecular
ubtypes (luminal A, luminal B, HER2-enriched, Basal, and Normal-
ike) [11]. Generally, ER and PgR positive status is associated with
n improved differentiation of tumors and improved clinical out-
ome [9]. HER2 over-expression is known to have a poor prognosis
n breast tumors [12]. Although IMPC has an aggressive behavior,
any studies have reported that IMPC is characterized by higher
ates of ER and PgR expression compared to other breast cancer
ypes [6–10]. However, this is controversial as other reports have
entioned a low rate of ER expression in IMPC [13]. In our case, the
umor was negative for the ER and PgR receptors, and positive for
ER2. Although our case was different from more frequent IMPC
ntrinsic type, the examined tumor had an aggressive behavior as it
as HER2-enriched. The exact etiology of intratumoral hemorrhage
s unknown, but the malignant behavior of the IMPC component is
onsidered to be the cause of a rapid tumor growth that is enhanced
y hemorrhage with in the tumor.
. Conclusion
Rapidly enlarging breast tumors are clinically rare, and only one
ase of breast carcinoma with rapid enlargement caused by intra-
umoral hemorrhage has been reported to date. IMPC is known
o have an aggressive behavior compared to invasive ductal car-
inoma. This type of malignancy may  have caused a rapid tumor
rowth due to hemorrhage in our case. Owing to the aggressive clin-
cal behaviors of IMPC, in addition to pathologists, surgeons should
lso be able to directly recognize the morphology of IMPC; in this
ay, treatment will be provided in an earlier disease stage.
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